Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody

BACKGROUND: Immune checkpoint inhibitors have revolutionized cancer therapy since these drugs target inhibitory pathways on T cells, which result in durable anti-tumor immune responses and significant overall survival for a subset of cancer patients. These drugs can also lead to toxicities, which re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilen, Mehmet Asim, Subudhi, Sumit K., Gao, Jianjun, Tannir, Nizar M., Tu, Shi-Ming, Sharma, Padmanee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915058/
https://www.ncbi.nlm.nih.gov/pubmed/27330809
http://dx.doi.org/10.1186/s40425-016-0139-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915058/
https://www.ncbi.nlm.nih.gov/pubmed/27330809
http://dx.doi.org/10.1186/s40425-016-0139-8

Ejemplares similares